⚖️Revocation of DEA Registration for Mohan Kaza Due to Violations
The Drug Enforcement Administration issued a decision revoking Dr. Mohan Kaza's DEA registration, citing multiple violations of the Controlled Substances Act related to improper prescribing practices. The order reveals serious concerns regarding public safety and compliance with legal standards, ultimately leading to the termination of his ability to prescribe controlled substances.
Learn More⚖️DEA Registration Revocation for Prescription Violations
The Drug Enforcement Administration (DEA) issued a decision revoking a medical doctor's registration due to issuing controlled substance prescriptions without state authority, violating both federal and state law. The order underscores the importance of compliance with healthcare regulations to safeguard public health and safety.
Learn More🏥NIH Meeting Notice
The NIH announces a hybrid meeting of the Council of Councils, focusing on grant applications and program updates. The meeting will provide insights into funding opportunities and NIH initiatives. Participants can engage virtually or in-person, ensuring accessibility for stakeholders interested in research and funding initiatives.
Learn More💊FDA's Generic Drug User Fee Program Information Collection Overview
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Learn More📅NIH Grant Review Committee Meetings
The Department of Health and Human Services announces closed meetings of various National Institutes of Health committees to review grant applications. The meetings aim to evaluate proposals within specific sectors, emphasizing the confidentiality of trade secrets and personal data. These sessions provide valuable insights into funding opportunities for businesses involved in health-related research and development.
Learn More🚚FMCSA Denies ICD Exemptions for Commercial Drivers
FMCSA announces its decision to deny the applications of two individuals treated with an Implantable Cardioverter Defibrillator (ICD) who requested an exemption from the Federal Motor Carrier Safety Regulations (FMCSRs) prohibiting operation of a commercial motor vehicle (CMV) in interstate commerce by persons with a current clinical diagnosis of myocardial infarction, angina pectoris, coronary insufficiency, thrombosis, or any other cardiovascular disease of a variety known to be accompanied by syncope (transient loss of consciousness), dyspnea (shortness of breath), collapse, or congestive heart failure.
Learn More🧬FDA Draft Guidance on Disease Risks in Human Cells, Tissues
The Food and Drug Administration (FDA or the Agency) is withdrawing two final guidances entitled "Recommendations to Reduce the Risk of Transmission of Disease Agents Associated with Sepsis by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)" and "Recommendations to Reduce the Risk of Transmission of Mycobacterium Tuberculosis (Mtb) by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)" and reissuing them as draft guidances.
Learn More🩺Proposed Collection of US Marshals Service Medical Information
The US Marshals Service, Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Learn More🏥NIH Announces Closed Meetings for Grant Application Evaluations
The Department of Health and Human Services announces closed meetings by the National Institutes of Health's Center for Scientific Review, set to evaluate grant applications on cardiovascular sciences and health disparities. The meetings will be virtual, emphasizing confidentiality regarding confidential trade secrets and personal information involved in the applications.
Learn More🩺FDA Notice on Xenotransplantation and Infectious Disease Guidelines
The Food and Drug Administration (FDA, Agency, or we) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to this notice. This notice solicits comments on the collection of information contained in the Public Health Service (PHS) guideline entitled "PHS Guideline on Infectious Disease Issues in Xenotransplantation" dated January 19, 2001.
Learn More